Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $618.29 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $169.12 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $163.75 | 9 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $115.72 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $44.06 | 2 | $0 (2024) |
| Alkermes, Inc. | $40.52 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.87 | 2 | $0 (2024) |
| Neuronetics, Inc. | $25.92 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $20.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $618.29 | 29 | ABBVIE INC. ($169.12) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $115.72 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: CNS | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.92 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 10/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CNS | ||||||
| 10/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Neuropsychiatry | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: NEUROSCIENCE | ||||||
About Michelle Millspaw, PMHNP
Michelle Millspaw, PMHNP is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2024. The National Provider Identifier (NPI) number assigned to this provider is 1063249233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Millspaw, PMHNP has received a total of $618.29 in payments from pharmaceutical and medical device companies, with $618.29 received in 2024. These payments were reported across 29 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($618.29).
Practice Information
- Specialty Psychiatric/Mental Health
- Location Virginia Beach, VA
- Active Since 09/19/2024
- Last Updated 02/01/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063249233
Products in Payments
- VRAYLAR (Drug) $169.12
- FANAPT (Drug) $115.72
- REXULTI (Drug) $88.04
- ABILIFY MAINTENA (Drug) $52.11
- INGREZZA (Drug) $44.06
- ARISTADA (Drug) $40.52
- TRINTELLIX (Drug) $38.87
- NEUROSTAR TMS THERAPY SYSTEM (Device) $25.92
- ABILIFY ASIMTUFII (Drug) $23.60
- COBENFY (Drug) $20.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301